Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gray Zone”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)UnknownNCT04860674
What this trial is testing

A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Who this might be right for
Gray Zone LymphomaRelapse/RecurrenceChemotherapy Effect
Zhejiang Cancer Hospital 20
Not applicableEnded earlyNCT04559178
What this trial is testing

Fluid Challenges and Microcirculation

Who this might be right for
Surgery
Erasme University Hospital 10
Not applicableWithdrawnNCT01898975
What this trial is testing

A Gray Zone Approach to Stroke Volume Variation Derived From NICOM

Who this might be right for
Neurological Diseases or ConditionsFluid ResponsivenessNon Invasive Cardiac Output Monitoring+1 more
Samsung Medical Center
Not applicableUnknownNCT04905329
What this trial is testing

Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Who this might be right for
Solid TumorHigh-Risk CancerBreast Cancer+3 more
Moscow Clinical Scientific Center 285
Early research (Phase 1)Active Not RecruitingNCT03602157
What this trial is testing

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Who this might be right for
LymphomaImmune System DiseasesImmunoproliferative Disorders+10 more
UNC Lineberger Comprehensive Cancer Center 43
Not applicableUnknownNCT03488706
What this trial is testing

Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level

Who this might be right for
Prostate Cancer
CellMaxLife 500
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Not applicableStudy completedNCT04118244
What this trial is testing

A Functional Test to Assess Fluid Status During Lung Protective Ventilation Strategies

Who this might be right for
Patients Receiving Protective Lung VentilationPatients in Grey Zone (3 < Pulse Pressure Variation (PPV) < 17
Hallym University Kangnam Sacred Heart Hospital 48
Not applicableUnknownNCT05483049
What this trial is testing

Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone

Who this might be right for
Chronic Hepatitis b
Ruijin Hospital 600
Testing effectiveness (Phase 2)Study completedNCT03255018
What this trial is testing

Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas

Who this might be right for
Non-Hodgkin LymphomaLymphomaDiffuse Large B-Cell Lymphoma+2 more
National Cancer Institute (NCI) 12
Not applicableUnknownNCT04792112
What this trial is testing

Navigating the Grey Zone for Antenatal Corticosteroids

Who this might be right for
Decision Making, SharedPregnancyPreterm Birth
University of British Columbia 460
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT02425969
What this trial is testing

A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values

Who this might be right for
Grey-zone Fractional Flow ReserveIntermediate Coronary LesionsStable Angina+1 more
Golden Jubilee National Hospital 108
Not applicableStudy completedNCT06029088
What this trial is testing

Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Ankara Etlik City Hospital 616
Not applicableStudy completedNCT01844219
What this trial is testing

Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach

Who this might be right for
Aortic SurgeryPostoperative Acute Kidney Injury
Samsung Medical Center 375
Not applicableUnknownNCT04251546
What this trial is testing

Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV

Who this might be right for
Prostate CancerPSA
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)WithdrawnNCT03241017
What this trial is testing

Durvalumab in DLBCL After Autologous Transplant

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Insel Gruppe AG, University Hospital Bern
Early research (Phase 1)Study completedNCT02568553
What this trial is testing

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Load More Results